Literature DB >> 18377447

The contribution of complications to high resource utilization during congenital heart surgery admissions.

Oscar J Benavidez1, Jean A Connor, Kimberlee Gauvreau, Kathy J Jenkins.   

Abstract

BACKGROUND: The Institutes of Medicine estimates that patient safety events cost the United States between $17 billion and $29 billion annually. Costs associated with patient safety events or complications among congenital heart surgery admissions are understudied.
OBJECTIVE: To determine the independent contribution of complications on increased resource utilization during congenital heart surgery admissions. DESIGN/
METHODS: Data were obtained from the Healthcare Cost and Utilization Project Kids' Inpatient Database year 2000. Cases of congenital heart surgery <18 years of age were identified. High resource use admissions were defined as admissions above the 90th percentile for total hospital charges. Complications were identified by a method published by the Agency for Healthcare Research Quality using ICD-9-CM codes. Multivariate analyses using generalized estimating equations adjusted for previously identified factors associated with high resource use to estimate the independent effect of a complication on high resource use. These factors include: Risk Adjustment for Congenital Heart Surgery risk categories, age, prematurity, major noncardiac structural anomalies, Medicaid, weekend admission, and state. The added explanatory power attributed to a complication diagnosis variable was measured by an increase in the area under the receiver operator characteristic curve (ROC).
RESULTS: Among 10,602 congenital heart surgery admissions identified, the median total charges were $51,125. The threshold for high resource use was total charges >or=$192,272. High resource admissions accounted for >40% of the total charges for all admissions. Complications were identified in 3360 (32%) of congenital heart surgery admissions. Univariate analysis demonstrated that admissions with at least 1 complication diagnosis were more likely to be a high resource use admission (18% vs. 6%, OR 3.0, P < 0.001). Multivariate analyses revealed that admissions with a complication diagnosis were much more likely to exceed the threshold for high resource utilization (OR 3.2, P < 0.001). The addition of the complication variable to the multivariate model increased the area under the ROC curve from 0.837 to 0.863.
CONCLUSIONS: Congenital heart surgery admissions with a complication diagnosis are 3 times more likely to exceed $192 272 in total charges despite adjusting for known risk factors for high resource use. Complication reduction may result in both an economic and clinical benefit.

Entities:  

Mesh:

Year:  2007        PMID: 18377447     DOI: 10.1111/j.1747-0803.2007.00119.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  20 in total

1.  The Impact of Differential Case Ascertainment in Clinical Registry Versus Administrative Data on Assessment of Resource Utilization in Pediatric Heart Surgery.

Authors:  David W Jantzen; Xia He; Jeffrey P Jacobs; Marshall L Jacobs; Michael G Gaies; Matt Hall; John E Mayer; Samir S Shah; Jennifer Hirsch-Romano; J William Gaynor; Eric D Peterson; Sara K Pasquali
Journal:  World J Pediatr Congenit Heart Surg       Date:  2014-07

2.  Factors associated with inpatient hospitalizations among patients aged 1 to 64 years with congenital heart defects, Arkansas 2006 to 2011.

Authors:  Regina M Simeone; Matthew E Oster; Charlotte A Hobbs; James M Robbins; R Thomas Collins; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-07-14

3.  Surgical management of congenital heart disease: contribution of the Aristotle complexity score to planning and budgeting in the German diagnosis-related groups system.

Authors:  Nicodème Sinzobahamvya; Joachim Photiadis; Thorsten Kopp; Claudia Arenz; Christoph Haun; Ehrenfried Schindler; Viktor Hraska; Boulos Asfour
Journal:  Pediatr Cardiol       Date:  2011-07-29       Impact factor: 1.655

4.  Variation in congenital heart surgery costs across hospitals.

Authors:  Sara K Pasquali; Marshall L Jacobs; Xia He; Samir S Shah; Eric D Peterson; Matthew Hall; J William Gaynor; Kevin D Hill; John E Mayer; Jeffrey P Jacobs; Jennifer S Li
Journal:  Pediatrics       Date:  2014-02-24       Impact factor: 7.124

5.  Impact of pediatric cardiac surgery regionalization on health care utilization and mortality.

Authors:  Rie Sakai-Bizmark; Laurie A Mena; Hiraku Kumamaru; Ichiro Kawachi; Emily H Marr; Eliza J Webber; Hyun H Seo; Scott I M Friedlander; Ruey-Kang R Chang
Journal:  Health Serv Res       Date:  2019-03-27       Impact factor: 3.402

6.  Predictors of Extended Length of Hospital Stay Following Surgical Repair of Congenital Heart Diseases.

Authors:  Ahmad Saeed Azhar; Hasan Mohamed Aljefri
Journal:  Pediatr Cardiol       Date:  2018-08-31       Impact factor: 1.655

7.  Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database.

Authors:  Carissa M Baker-Smith; Sara W Goldberg; Geoffrey L Rosenthal
Journal:  Pediatr Cardiol       Date:  2015-06-03       Impact factor: 1.655

8.  Surgical volume, hospital quality, and hospitalization cost in congenital heart surgery in the United States.

Authors:  Titus Chan; Jaewhan Kim; L LuAnn Minich; Nelangi M Pinto; Norman J Waitzman
Journal:  Pediatr Cardiol       Date:  2014-08-07       Impact factor: 1.655

9.  Regional Differences in Cost and Length of Stay in Neonates with Hypoplastic Left Heart Syndrome.

Authors:  Luma Essaid; Paula D Strassle; Eric G Jernigan; Jennifer S Nelson
Journal:  Pediatr Cardiol       Date:  2018-05-12       Impact factor: 1.655

10.  Rising charges and costs for pediatric catheter ablation.

Authors:  Kristin M Burns; Frank Evans; Gail D Pearson; Charles I Berul; Jonathan R Kaltman
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.